Skip to main content

Table 4 Percentage of patients on monotherapy during the complete biologic course, according to biologic treatment course

From: Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice

  1st Course 2nd Course 3rd Course 4th Course Total
Number of patients 79 25 9 2 115
% Patients on biologic monotherapy during the complete biologic course (95 % CI) 15 (8–25) 48 (28–69) 44 (14–79) 50 (13–99) 25 (18–34)
% Patients on biologic monotherapy during the complete biologic course due to Medical prescription (95 % CI) 10 (4–19) 40 (21–61) 33 (7–70) 0 18 (12–26)
% Patients biologic monotherapy during the complete biologic course due to patient’s decision (95 % CI) 5 (1–12) 8 (1–26) 11 (0.2–48) 50 (13–99) 7 (3–13)